Uterine Leiomyoma
23
0
0
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.7%
2 terminated out of 23 trials
88.9%
+2.4% vs benchmark
22%
5 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (23)
Effects of Oligo-fucoidan on Leiomyoma Patients
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy
Evaluating Serum Sestrin in Leiomyoma Patients
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.
Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM)
High Intensity Focused Ultrasound in Uterine Myoma
Postpartum Uterine Regression
Trial of a Patient Education Tool For Leiomyoma
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
Vaginal vs. Laparoscopic Hysterectomy
Directed Ablation of Uterine Fibroids Using a Noninvasive Approach
Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma